Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11 years with severe atopic dermatitis

被引：1
|
作者：
Flohr, Carsten [1 ,2 ]
Irvine, Alan D. [3 ]
Cork, Michael J. [4 ,5 ]
Simpson, Eric L. [6 ]
Wollenberg, Andreas [7 ,8 ]
Deleuran, Mette [9 ]
Praestgaard, Amy [10 ]
Thomas, Ryan B. [11 ]
Rossi, Ana B. [10 ]
机构：
[1] Kings Coll London, Dept Paediat Dermatol, St Johns Inst Dermatol, London, England
[2] Guys & St Thomas NHS Fdn Trust, London, England
[3] Trinity Coll Dublin, Clin Med, Dublin, Ireland
[4] Univ Sheffield, Dept Infect Immun & Cardiovasc Dis, Sheffield Dermatol Res, Sheffield, England
[5] Sheffield Childrens Hosp, Sheffield, England
[6] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR USA
[7] Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergy, Munich, Germany
[8] Free Univ Brussels, Univ Hosp, Dept Dermatol, Brussels, Belgium
[9] Aarhus Univ Hosp, Aarhus, Denmark
[10] Sanofi, Cambridge, MA 02142 USA
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 02期
关键词：
INITIAL VALIDATION;
D O I：
10.1093/bjd/ljad124
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：238 / 240
页数：3
相关论文
共 50 条
  • [21] Dupilumab significantly improves atopic dermatitis in children aged 6-11 years: results from a phase III trial (LIBERTY AD PEDS)
    Paller, A. S.
    Siegfried, E. C.
    Gooderham, M.
    Beck, L. A.
    Boguniewicz, M.
    Sher, L.
    Weisman, J.
    Staudinger, H. W.
    Sun, X.
    Shumel, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 (04) : E121 - E121
  • [22] Dupilumab improves Eczema Area and Severity Index regional scores across all anatomical regions in children aged 6-11 years with severe atopic dermatitis (AD)
    Paller, Amy S.
    Cork, Michael J.
    Marcoux, Danielle
    Wollenberg, Andreas
    Prescilla, Randy
    Chen, Zhen
    Rossi, Ana B.
    Shumel, Brad
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB136 - AB136
  • [23] Impact of dupilumab on health-related quality of life in patients with atopic dermatitis
    Rencz, F.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (02) : 319 - 320
  • [24] Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic Dermatitis
    Lio, Peter A.
    Armstrong, April
    Gutermuth, Jan
    Nosbaum, Audrey
    Sofen, Howard
    Gil, Esther Garcia
    Casillas, Marta
    Chen, Sherry
    Sun, Luna
    Pierce, Evangeline
    Elmaraghy, Hany
    Dawson, Zach
    Torres, Tiago
    DERMATOLOGY AND THERAPY, 2024, 14 (07) : 1929 - 1943
  • [25] Dupilumab is effective in children aged 6-11 years with severe atopic Dermatitis (AD) regardless of baseline serum total immunoglobulin E levels
    Cork, Michael J.
    Wollenberg, Andreas
    Siegfried, Elaine C.
    Arkwright, Peter D.
    Chen, Zhen
    Levit, Noah A.
    Marco, Ainara Rodriguez
    Radwan, Amr
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (12): : 1659 - 1659
  • [26] Dupilumab rapidly improves atopic dermatitis symptoms in children aged ≥ 6 to < 12 years as measured by POEM
    Silverberg, J. I.
    Eichenfield, L. F.
    Wollenberg, A.
    Praestgaard, A.
    Delevry, D.
    Rossi, A. B.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E119 - E119
  • [27] Dupilumab improves signs, symptoms, and quality of life in adolescents with moderate to severe atopic dermatitis
    Eichenfield, Lawrence F.
    Silverberg, Jonathan I.
    Gadkari, Abhijit
    Guillemin, Isabelle
    Chen, Zhen
    Bansal, Ashish
    Eckert, Laurent
    Rosner, Karli
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB26 - AB26
  • [28] Dupilumab Treatment in Pediatric Patients Aged 6-11 Years with Severe Atopic Dermatitis Whose Disease Is Not Adequately Controlled: A Review
    Cork, Michael J.
    Danby, Simon G.
    Rossi, Ana B.
    Bansal, Ashish
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 277 - 289
  • [29] Dupilumab treatment leads to mild transient increases in eosinophil levels without clinical relevance in children aged 6-11 years with severe atopic dermatitis
    Paller, Amy
    Wollenberg, Andreas
    Cork, Michael
    Siegfried, Elaine
    Chen, Zhen
    Vakil, Jignesh
    Levit, Noah
    Marco, Ainara Rodriguez
    Radwan, Amr
    CLINICAL AND EXPERIMENTAL ALLERGY, 2021, 51 (12): : 1687 - 1688
  • [30] Dupilumab Treatment Improves Sleep Quality in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis and Their Caregivers
    Paller, Amy S.
    Simpson, Eric L.
    Siegfried, Elaine C.
    Cork, Michael J.
    Wollenberg, Andreas
    Arkwright, Peter D.
    Praestgaard, Amy
    Prescilla, Randy
    Wang, Zhixiao
    Marco, Ainara Rodriguez
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
12345